Trump’s FDA Chief Takes Wide Aim at Opioid Addiction Crisis
July 25, 2017
Gottlieb said he wants to examine whether insurers and pharmacy benefit managers, or PBMs, can reduce the number of pills...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Highlights
- Biosimilars
- Drug Abuse Prevention
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- Specialty Pharmacies
- TRICARE
Drug makers to blame for high prescription prices
July 25, 2017
When it comes to how high they price their products, drug companies want the public to ignore what they spend...
Increasing Competition Can Reduce Prescription Drug Prices
July 24, 2017
Reducing prescription drug prices for payers requires market-based solutions that increase competition and deregulate federal drug policies, PCMA wrote in...
PBM lobby defends rebates in letter to Price
July 19, 2017
Pharmaceutical Care Management Association president Mark Merritt told Price that: 1) Most payers elect to receive 90 percent of rebates...
Pharmaceuticals share much of the blame for rising drug costs
July 15, 2017
Instead of simply acknowledging their pricing strategies, drug companies and their lobbyists have launched a finger pointing campaign at pharmacy...
July 12, 2017
The basic fact: Drug companies set the price of the drug. They can charge whatever they feel the market will...
Medicare will remain solvent until 2029, trustees say
July 10, 2017
Medicare’s hospital trust fund is expected to run out of money in 2029, the program’s trustees said in a new...
Amgen, Teva hikes show pharma can’t blame rebates for all price increases: analyst
July 09, 2017
One analyst is pointing to two increases—both involving cancer drugs—as evidence that drugmakers sometimes raise prices simply “because they can.”...
Rebates not to blame for rising drug costs, says PBM trade group
June 15, 2017
PCMA’s report adds new evidence pushing back on that line of thought. According to the study, drugmakers raised list prices...
Drug Prices Become Target for FDA as Chief Expands Purview
June 06, 2017
The FDA is also looking into whether it can publish a list of the 180 brand-name drugs that no longer...
How Do Manufacturer Rebates Impact Drug Prices?
April 26, 2017
A statistical analysis revealed there was no correlation between price increases and rebates, according to the study. The authors found...
Blame drug makers for high-priced drugs
April 17, 2017
When it comes to how high they price their products, drug companies want the public to ignore what they spend...